<DOC>
	<DOCNO>NCT02305940</DOCNO>
	<brief_summary>This study investigate long term use antibiotic doxycycline reduce exacerbation COPD patient . Half patient receive doxycycline half receive placebo .</brief_summary>
	<brief_title>Effects Long Term Antibiotic Therapy Exacerbation Rate Stable COPD Patients</brief_title>
	<detailed_description>Chronic Obstructive Pulmonary Disease ( COPD ) common disease place considerable burden people suffer . COPD exacerbation ( period symptom flare ) major cause hospital admission UK . Bacterial infection play important role development COPD one possible treatment COPD antibiotic . However , little information available use long term antibiotic treatment disease . Therefore , purpose study investigate long term use antibiotic Doxycycline reduce exacerbation improve outlook patient .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>Informed consent give Confirmed COPD diagnosis Severity disease : Patients measure FEV1 &lt; 80 % predict normal value . At least one treat exacerbation ( Patient recall episode symptomatic worsening treat consistent COPD exacerbation ) previous year . Age : â‰¥ 45 year age screening . Able complete questionnaire health status symptom consider able comply dose regimen . Patients willing report exacerbation attend study visit . Patients know diagnosis active TB chronic respiratory disease judgement study doctor . Hepatic renal impairment define LFTs &gt; 5XULN , eGFR &lt; 30 ml/min/1.73m2 . Patients know hypersensitivity Tetracyclines , IMP and/or Placebo include excipients . Patients take ongoing antibiotic therapy COPD condition . Patients uncontrolled clinically significant hypertension Female patient pregnant plan become pregnant study , breastfeed . Patients uncontrolled clinically relevant bradycardia , cardiac arrhythmia cardiac insufficiency . Clinically relevant abnormal electrolyes ( sodium potassium ) , renal function ( urea creatinine ) liver function ( ALT , AST , ALP ) could interfere objective trial safety volunteer . Patient take clinically significant contraindicated medication , per SmPC Doxycycline . Use another experimental investigational medicinal product within 3 month study enrolment . If IMP use part NIHR WP2 study entry WP3 6 week washout period permissible . Patients condition preclude enrolment trial , accord assessment study doctor . This document screening</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>